LoginRegister
    Catalyst Pharma files lawsuit against USFDA challenging approval of RuzurgiCatalyst Pharma files lawsuit against USFDA challenging approval of Ruzurgi
    End of ENDS: CDSCO moves to ban electronic smoking devices by classifying them as DRUGSEnd of ENDS: CDSCO moves to ban electronic smoking devices by classifying them as DRUGS
    Yes Bank reduces stake in Fortis Healthcare by selling shares worth over Rs 1.51 croreYes Bank reduces stake in Fortis Healthcare by selling shares worth over Rs 1.51 crore
    Merck wins USFDA nod for blockbuster drug Keytruda to treat head, neck cancerMerck wins USFDA nod for blockbuster drug Keytruda to treat head, neck cancer
    Eye care chain Disha Medical Services raises over Rs 27 crore in Series C fundingEye care chain Disha Medical Services raises over Rs 27 crore in Series C funding
    Practo collaborates with Academy of Family Physicians of India to develop digital healthcare technologyPracto collaborates with Academy of Family Physicians of India to develop digital healthcare...
    Roche appoints Thomas Schinecker as new head of $13 billion diagnostics unitRoche appoints Thomas Schinecker as new head of $13 billion diagnostics unit
    CDSCO apex committee streamlines drug approval process post clinical trialCDSCO apex committee streamlines drug approval process post clinical trial
    Delhi High Court directs RSSB chief Dhillon, family to undertake Singh brothers dues to DaiichiDelhi High Court directs RSSB chief Dhillon, family to undertake Singh brothers dues to Daiichi
    Abbott expands cardiac arrhythmias portfolio in India with launch of advanced mapping catheterAbbott expands cardiac arrhythmias portfolio in India with launch of advanced mapping catheter
    Cipla receives inspection report from USFDA for Kurkumbh facilityCipla receives inspection report from USFDA for Kurkumbh facility
    Roche gets USFDA nod for combo lymphoma treatment PolivyRoche gets USFDA nod for combo lymphoma treatment Polivy
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X